Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Fever in the neutropenic host INFECTIOUS DISEASE CLINICS OF NORTH AMERICA Chanock, S. J., Pizzo, P. A. 1996; 10 (4): 777-?

Abstract

Fever in the neutropenic patient following myelosuppressive chemotherapy is a medical emergency. Appropriate antimicrobial therapy can dramatically reduce infection-related morbidity and mortality. This article reviews the rationale and methodology of treatment as well as its applicability to other neutropenic states. The utility of adjunct therapy with granulocyte- stimulating compounds is also discussed.

View details for Web of Science ID A1996VX66500006

View details for PubMedID 8958168